Copyright
©The Author(s) 2025.
World J Gastroenterol. May 21, 2025; 31(19): 101913
Published online May 21, 2025. doi: 10.3748/wjg.v31.i19.101913
Published online May 21, 2025. doi: 10.3748/wjg.v31.i19.101913
Table 1 Patient characteristics at baseline
| Characteristics | Sequential group, overall | Sequential group, side by side | Sequential group, stent in stent | Simultaneous group | P value |
| Number of patients | 73 | 35 | 38 | 62 | |
| Male | 41 (56) | 21 (51) | 20 (49) | 35 (56) | 0.82 |
| Age, years, median | 71 | 71 | 71 | 68 | 0.59 |
| Tumor type | 0.32 | ||||
| Cholangiocarcinoma | 34 (47) | 19 (54) | 15 (39) | 38 (61) | |
| Hilar metastasis | 34 (47) | 14 (40) | 20 (53) | 21 (34) | |
| Hepatocarcinoma | 5 (6) | 2 (6) | 3 (8) | 3 (5) | |
| Bismuth and Corlette classification | 0.053 | ||||
| II | 1 (1) | 0 (0) | 1 (2) | 8 (12) | |
| IIIa | 17 (23) | 11 (31) | 6 (16) | 9 (15) | |
| IIIb | 5 (7) | 2 (6) | 3 (8) | 9 (15) | |
| IV | 50 (69) | 22 (63) | 28 (74) | 36 (58) | |
| Bilirubin rate, day 0, μmol/L, median (IQR) | 224 (158-340) | 238 (162-342) | 220 (150-338) | 225 (132-334) | 0.80 |
| Postoperative chemotherapy | 25 (36) | 14 (42) | 11 (30) | 31 (53) | 0.095 |
| Survival time, days, median (IQR) | 61 (39-78) | 69 (43-128) | 43 (27-65) | 67 (56-105) | 0.24 |
- Citation: Guilmoteau T, Rouquette O, Buisson A, Cambier S, Abergel A, Poincloux L. Direct comparison of simultaneous and sequential endoscopic metallic bilateral stenting in malignant hilar biliary obstruction. World J Gastroenterol 2025; 31(19): 101913
- URL: https://www.wjgnet.com/1007-9327/full/v31/i19/101913.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i19.101913